Korean J Med.
2020 Apr;95(2):119-123. 10.3904/kjm.2020.95.2.119.
Azathioprine-Induced Non-Cirrhotic Portal Hypertension in a Patient with Crohn’s Disease
- Affiliations
-
- 1Division of Gastroenterology, Department of Internal Medicine, Fatima Hospital, Daegu, Korea
- KMID: 2501905
- DOI: http://doi.org/10.3904/kjm.2020.95.2.119
Abstract
- Thiopurine-based drugs such as azathioprine and 6-MP are among the most common immunosuppressants used to treat inflammatory bowel disease, autoimmune hepatitis, various autoimmune diseases, and patients undergoing organ transplantation. The drugs are associated with various complications, of which one of the most serious is hepatotoxicity that may trigger non-cirrhotic portal hypertension. We report a case with this side-effect in a patient taking azathioprine to treat Crohn’s disease.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Non-cirrhotic portal hypertension related to azathioprine therapy in a patient with Crohn’s disease
- Balloon Occlusion Retrograde Transvenous Obliteration of Gastric Varices in Two Non-Cirrhotic Patients with Portal Vein Thrombosis
- Unusual Complication of Crohn's Disease: Portal Hypertension Related with Rapid Progression of Portal Vein and Superior Mesenteric Vein Thrombosis
- Acute Pancreatitis Induced by Azathioprine and 6-mercaptopurine Proven by Single and Low Dose Challenge Testing in a Child with Crohn Disease
- Determining the Dose of Azathioprine Based on the Lower Limit of Leukocyte Count in Patients with Crohn's Disease
